Physician profile
John Leonard
NPI 1275196206
$7,770.02
in general payments reported to CMS, 2019-2025
9 companies · $4,040 in 2025
The $4,040 reported for 2025 was more than what 98% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,730 · 2025: $4,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,539 · Food and Beverage: $3,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,538.50 |
| Food and Beverage | $3,231.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,126.99 | 2024-2025 | Gallant, Mitraclip, Merlin@Home |
| Cvrx, INC. | $2,818.03 | 2024-2025 | Barostim Neo System |
| Boston Scientific Corporation | $843.92 | 2025 | Watchman Access System |
| Medtronic, INC. | $579.01 | 2024 | |
| Biosense Webster, INC. | $281.10 | 2024-2025 | Soundstar, Nuvision Ice Catheter, Carto 3 |
| Abiomed | $41.70 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.02 | 2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $27.16 | 2025 | Amvuttra |
| Astrazeneca Pharmaceuticals LP | $17.09 | 2025 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Leonard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.